Get the Stockscreener App
39.14
0.63%
-0.25
Amphastar Pharmaceuticals Inc stock is traded at $39.14, with a volume of 2.07M.
It is down -0.63% in the last 24 hours and down -11.23% over the past month.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$39.39
Open:
$39.31
24h Volume:
2.07M
Relative Volume:
5.00
Market Cap:
$1.88B
Revenue:
$723.55M
Net Income/Loss:
$157.72M
P/E Ratio:
20.07
EPS:
1.95
Net Cash Flow:
$170.15M
1W Performance:
-7.34%
1M Performance:
-11.23%
6M Performance:
-1.61%
1Y Performance:
-33.13%
1-Day Range:
$38.96
$40.74
1-Week Range:
$38.78
$42.49
52-Week Range:
$36.56
$65.92
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
39.14 | 1.88B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
19,723 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by Wellington Management Group LLP - MarketBeat
Hyaluronidase Market Massive Growth Predicted (2024-2031) | - openPR
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 7,000 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals executive sells shares worth $672,815 - Investing.com
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Prospects Need A Boost To Lift Shares - Simply Wall St
World Investment Advisors LLC Takes $1.61 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 5.4%What's Next? - MarketBeat
XTX Topco Ltd Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
The Manufacturers Life Insurance Company Trims Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Decreased by Centiva Capital LP - MarketBeat
Point72 Asset Management L.P. Sells 197,019 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals Breaks Above 200-Day Moving AverageBullish for AMPH - Nasdaq
Charles Schwab Investment Management Inc. Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Taika Capital LP Makes New $1.79 Million Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today? - Yahoo Finance
Hotchkis & Wiley Capital Management LLC Acquires Shares of 222,620 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options - Yahoo Finance
BNP Paribas Financial Markets Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Dynamic Technology Lab Private Ltd Sells 11,224 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Glenmede Trust Co. NA Buys 22,439 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Where are the Opportunities in (AMPH) - Stock Traders Daily
Intech Investment Management LLC Purchases 2,331 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Thrivent Financial for Lutherans - Defense World
Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now? - Yahoo Finance
12 Most Profitable Pharmaceutical Stocks Right Now - Insider Monkey
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors - Simply Wall St
Financial Review: UroGen Pharma (NASDAQ:URGN) and Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference - AccessWire
Amphastar Continues To Push Proprietary Portfolio With Focus On Baqsimi - Citeline
Algert Global LLC Purchases New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar initiated with an Equal Weight at Wells Fargo - MSN
Connor Clark & Lunn Investment Management Ltd. Sells 20,448 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Segall Bryant & Hamill LLC Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated at Wells Fargo & Company - Defense World
Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle By Investing.com - Investing.com South Africa
GSA Capital Partners LLP Invests $303,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Wells Fargo Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight Recommendation - MSN
Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle - Investing.com
Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016. - Marketscreener.com
Victory Capital Management Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Victory Capital Management Inc. Has $10.61 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Injectables Contraceptives Market with Promising Opportunity - openPR
Principal Financial Group Inc. Has $9.80 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat
Amphastar Pharmaceuticals executive sells $336,929 in stock By Investing.com - Investing.com Australia
Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com
Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire
Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan
Amphastar Pharmaceuticals Inc (AMPH) Stock Price Down 3.5% on No - GuruFocus.com
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amphastar Pharmaceuticals Inc Stock (AMPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 12 '24 |
Option Exercise |
11.33 |
7,000 |
79,310 |
125,469 |
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 13 '24 |
Sale |
45.23 |
8,000 |
361,840 |
118,469 |
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 12 '24 |
Sale |
44.42 |
7,000 |
310,975 |
118,469 |
| PRINS RICHARD K | Director |
Dec 09 '24 |
Option Exercise |
19.52 |
10,000 |
195,200 |
40,471 |
| PRINS RICHARD K | Director |
Dec 09 '24 |
Sale |
43.77 |
10,000 |
437,702 |
30,471 |
1.61%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):